A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for Major Depressive Disorder
26 locations incl. Little Rock
Sponsor: Definium Therapeutics US, Inc.
Sex: All·Age: 18 - 74
Code: NCT07592689·Phase 3·Recruiting·Listed May 2026
Clinical research site in San Francisco, California · 513 PARNASSUS AVE, S-321, SAN FRANCISCO, CA 94143-2205 · (415) 476-4380
Part of UCSF
As of July 2026, 4 paid clinical trials are recruiting at UCSF, Department of Neurosurgery in San Francisco, California. Active studies at this site cover conditions such as Major Depressive Disorder, Gender Dysphoria and Mastectomy. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in San Francisco, CA · California clinical trials